Copyright
©2014 Baishideng Publishing Group Inc.
Figure 4 Schematic representation of HER2-targeting ligands and conjugation strategies employed for NPs functionalization.
HER: Human epidermal growth factor receptor; scFv: Single-chain fragment variable antibodies.
- Citation: Mazzucchelli S, Truffi M, Fiandra L, Sorrentino L, Corsi F. Targeted approaches for HER2 breast cancer therapy: News from nanomedicine? World J Pharmacol 2014; 3(4): 72-85
- URL: https://www.wjgnet.com/2220-3192/full/v3/i4/72.htm
- DOI: https://dx.doi.org/10.5497/wjp.v3.i4.72